BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
5/26/16 CSL Ltd. (CSL:AU) Afstyla for Hemophilia A Subscribers Only Subscribers Only Subscribers Only
5/25/16 Sanofi (SNY) Lyxumia for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
5/25/16 Sanofi (SNY) LixiLan for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
5/25/16 Sarepta (SRPT) Eteplirsen for Muscular Dystrophy Subscribers Only Subscribers Only Subscribers Only
5/25/16 DelMar Pharmaceuticals (DMPI) VAL-083 for Brain Cancer (Malignant Glioma; AA and GBM) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
05/26/16 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
05/26/16 Subscribers Only Subscribers Only Company - Earnings Announcement
05/26/16 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 05/27/16 Subscribers Only Subscribers Only Trial Announcement - Trial Completion
Now - 05/27/16 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)